Skip to main content
HOPA Abstracts
Evaluating the Value of Clinical Oncology Pharmacists: Time-Savings for Healthcare Providers in The US Oncology Network
Abstract #LB02
Julianne Darling, PharmD, BCOP; Hilary Conkling, PharmD, BCOP; Alexa Basilio, PharmD, BCOP; Brittney Hale, PharmD, BCOP; Dan Kendzierski, PharmD, BCOP; Andrea Roman, PharmD, BCOP, et al.
Read More
HOPA Abstracts
Incorporation of a Statewide Cancer Drug Repository Program Within an Integrated Specialty Pharmacy
Abstract #LB03
Melisa McKendry, RPh, MSEd; Emily Mackler, PharmD, BCOP; Kimberly Melgarejo, PharmD, MHA; Siobhan Norman
Read More
HOPA Abstracts
Choice of Antifungal Prophylaxis and Risk for Invasive Fungal Disease in Patients With Acute Leukemia Receiving Oral Anticancer Therapies With Significant CYP450 Drug Interactions
Abstract #LB04
Matthew Yacobucci, PharmD, BCOP; Zhenzi Hong; Colby Webster; Alexis Gregoire; Ejemen Aigbedion
Read More
HOPA Abstracts
Evaluation of Fam-Trastuzumab Deruxtecan Utilization Among Patients With Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Abstract #LB05
Matt Arango, PharmD, BCOP; Hiba Alzouby, PharmD, BCOP; Ning Jin, MD; Ashish Manne, MBBS; Arjun Mittra, MD; Anne Noonan, MB ChB, PhD
Read More
HOPA Abstracts
Role of CYP2D6 Phenotypes in Doxorubicin-Related Cardiotoxicity
Abstract #LB06
Oksana O. Karpenko, PharmD, RPh, BCPS; Jodi L. Taraba, PharmD, MS, RPh, BCOP; Ross A. Dierkhising, MS; Kristin C. Cole, MS; Corina J. Doleski, PharmD, RPh, BCOP; Karthik V. Giridhar, MD, et al.
Read More
HOPA Abstracts
Implementation of an Oral Oncolytic Monitoring Pilot Program: A Specialty Pharmacist–Led Approach Using the Revised Edmonton Symptom Assessment System
Abstract #LB07
Clarissa Wilkins, PharmD, BCOP; Alexandra Ritenour, PharmD, CSP
Read More
HOPA Abstracts
Pressurized Intraperitoneal Aerosolized Chemotherapy: Operationalizing From a Pharmacy Perspective at a Large Academic Medical Center
Abstract #LB08
Aimee Merkert, PharmD; Megan Hinton, PharmD
Read More
Multiple Myeloma Education
Interview with the Innovators
Total Cost of Care for Bispecific Agents in Multiple Myeloma
Laura Bobolts, PharmD, BCOP, Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, Yonatan Resnick, PharmD
Read More
Multiple Myeloma Education
Interview with the Innovators
Clinical Pathways in Multiple Myeloma
Laura Bobolts, PharmD, BCOP, Kristen Boykin, PharmD, RPh/CPh, BCOP, BCPS, Hakan Kaya, MD, Lisa Raff, PharmD, MSPharm, BCPS, BCOP, Yonatan Resnick, PharmD
Read More
Clinical Trials
Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes
Read More
Page 14 of 196
Results 131 - 140 of 1953